Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Pediatric Blood & Cancer|January 27, 2021
General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor StudyJoanne F Chou, Jennifer S Ford, Ruth A Kleinerman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2013
Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastomaJasmine H Francis, Christopher A Barker, Suzanne L Wolden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer GroupI J Dunkel, J M Boyett, A Yates, et al.
Pediatric Blood & Cancer|November 13, 2009
Trilateral retinoblastoma: potentially curable with intensive chemotherapyIra J Dunkel, Rima F Jubran, Sri Gururangan, et al.
Pediatric Blood & Cancer|May 10, 2020
Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An updateDanielle Novetsky Friedman, Meier Hsu, Chaya S Moskowitz, et al.
JCO Precision Oncology|July 12, 2021
Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered GliomasSameer Farouk Sait, Stephen W Gilheeney, Tejus A Bale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2015
Psychosocial Outcomes in Adult Survivors of RetinoblastomaJennifer S Ford, Joanne F Chou, Charles A Sklar, et al.
Journal of Neuro-Oncology|November 5, 2018
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trialsDiana S Osorio, Neha Patel, Lingyun Ji, et al.
JAMA Ophthalmology|May 1, 2018
Vision-Targeted Health-Related Quality of Life in Adult Survivors of RetinoblastomaDanielle Novetsky Friedman, Joanne F Chou, Jasmine H Francis, et al.
Pediatric Neurology|June 21, 2015
Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology GroupBruce H Cohen, J Russell Geyer, Douglas C Miller, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Pediatric Blood & Cancer|January 27, 2021
General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor StudyJoanne F Chou, Jennifer S Ford, Ruth A Kleinerman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2013
Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastomaJasmine H Francis, Christopher A Barker, Suzanne L Wolden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer GroupI J Dunkel, J M Boyett, A Yates, et al.
Pediatric Blood & Cancer|November 13, 2009
Trilateral retinoblastoma: potentially curable with intensive chemotherapyIra J Dunkel, Rima F Jubran, Sri Gururangan, et al.
Pediatric Blood & Cancer|May 10, 2020
Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An updateDanielle Novetsky Friedman, Meier Hsu, Chaya S Moskowitz, et al.
JCO Precision Oncology|July 12, 2021
Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered GliomasSameer Farouk Sait, Stephen W Gilheeney, Tejus A Bale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2015
Psychosocial Outcomes in Adult Survivors of RetinoblastomaJennifer S Ford, Joanne F Chou, Charles A Sklar, et al.
Journal of Neuro-Oncology|November 5, 2018
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trialsDiana S Osorio, Neha Patel, Lingyun Ji, et al.
JAMA Ophthalmology|May 1, 2018
Vision-Targeted Health-Related Quality of Life in Adult Survivors of RetinoblastomaDanielle Novetsky Friedman, Joanne F Chou, Jasmine H Francis, et al.
Pediatric Neurology|June 21, 2015
Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology GroupBruce H Cohen, J Russell Geyer, Douglas C Miller, et al.
Pageof 24